Stada Expands Supply Network With Romanian Facility
Also Strikes German Deals With AOK And IKK For Cannabis Products
Executive Summary
Stada is investing nearly €50m in a Romanian supply-chain hub that it says will support future growth for the company, benefiting from its central European location. Meanwhile, the company has also struck medical cannabis deals with German insurers AOK and IKK.
You may also be interested in...
Dr Reddy’s Continues To Capitalize On German Cannabinoids With MediCane Launch
Dr Reddy's has announced that it will market MediCane’s medical cannabis portfolio across Germany, as part of a collaboration between the two companies which began last year.
Deal Watch: Amgen Taps Plexium's Expertise In Targeted Protein Degradation
Mersana will help J&J develop antibody-drug conjugates against three targets, while AstraZeneca out-licenses a candidate for peripheral artery disease to Regio.
Dr Reddy’s Steps Into 'Must-Be' Medical Cannabis Segment With German Deal
Dr Reddy’s enters high-potential medical cannabis fray with the acquisition of Nimbus Health in Germany. The segment has seen a flurry of activity over the recent past, including the $7.2bn acquisition of pioneer GW Pharmaceuticals.